Compare · BXS vs PPH
BXS vs PPH
Side-by-side comparison of BancorpSouth Bank (BXS) and VanEck Vectors Pharmaceutical ETF (PPH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BXS and PPH operate in n/a (n/a), so they compete in similar markets.
- BXS carries a market cap of $3.12B.
- BXS has more recent analyst coverage (2 ratings vs 0 for PPH).
BancorpSouth Bank
BancorpSouth Bank provides commercial banking and financial services to individuals and small-to-medium size businesses. The company operates through Banking Services Group, Mortgage, Insurance Agencies, Wealth Management, and General Corporate and Other segments. It accepts various deposit products, including interest and noninterest bearing demand deposits, and saving and other time deposits. The company also provides commercial loans, including term loans, lines of credit, equipment and receivable financing, and agricultural loans; a range of short-to-medium term secured and unsecured commercial loans to businesses for working capital, business expansion, and the purchase of equipment and machinery; and construction loans to real estate developers for the acquisition, development, and construction of residential subdivisions. In addition, it offers fixed and adjustable rate residential mortgage loans secured by owner-occupied property; construction loans; second mortgage loans; and home equity lines of credit, as well as non-residential consumer loans that consist of automobile, recreation vehicle, boat, personal, and deposit account secured loans, as well as issues credit cards. Further, the company operates as an agent for the sale of commercial lines of insurance; and offers a line of property and casualty, life, health, and employee benefits products and services. Additionally, it provides credit related products, trust and investment management, asset management, retirement and savings solutions, and estate planning and annuity products. As of March 4, 2021, the company operated through 305 full-service branch locations, as well mortgage, insurance, and loan production offices in Alabama, Arkansas, Florida, Louisiana, Mississippi, Missouri, Tennessee, and Texas; and an insurance location in Illinois. The company was formerly known as BancorpSouth, Inc. and changed its name to BancorpSouth Bank in October 2017. BancorpSouth Bank was founded in 1876 and is headquartered in Tupelo, Mississippi.
VanEck Vectors Pharmaceutical ETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest BXS
- SEC Form 13F-HR filed by BancorpSouth Bank
- BancorpSouth Bank and Cadence Bancorporation Complete Their Merger
- BancorpSouth Bank Declares Quarterly Common and Preferred Dividend
- BancorpSouth upgraded by Keefe Bruyette with a new price target
- Avid Bioservices Set to Join S&P SmallCap 600
- BancorpSouth Announces Third Quarter 2021 Results
- BancorpSouth Bank and Cadence Bancorporation Receive Final Regulatory Approval for Merger
- The First Agrees to Purchase Seven Cadence Bank Branches
- BancorpSouth Bank upgraded by Raymond James with a new price target
- BancorpSouth Adds Six New HOPE Inside Locations and Commits Nearly $1.5 Million to Operation HOPE for Financial Literacy Programs
Latest PPH
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
- Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
- 11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
- Biden-Harris Administration Moves Forward with Medicare Drug Price Negotiations to Lower Prescription Drug Costs for People with Medicare